Table 4: Effect of renal function for each CKD stage between Low PP group and High PP group.
Values are mean ± standard deviation where appropriate.
| (A) Low PP Group |
| CKD stage G3a-G3b (n=42) | CKD stage G4-G5 (n=26) |
| Renal function | baseline | 12 months later | p value | Baseline | 12 months later | p value |
| BUN (mg/dL) | 21.2±5.6 | 19.5±6.7 | 0.0537 | 34.1±13.9 | 39.1±16.2 | 0.0435 |
| SCr (mg/dL) | 1.2±0.3 | 4.2±2.0 | 0.5797 | 2.7±1.6 | 3.2±2.1 | 0.0029 |
| Ccr (mL/min) | 57.2±17.3 | 58.4±23.4 | 0.6872 | 28.1±18.8 | 23.3±12.3 | 0.0024 |
| eGFR (mL/min/1.73m2) | 46.9±9.3 | 48.1±11.5 | 0.4261 | 22.7±11.3 | 18.9±8.4 | 0.0014 |
| (B) High PP Group |
| CKD stage G3a-G3b (n=16) | CKD stage G4-G5 (n=20) |
| Renal function | baseline | 12 months later | p value | baseline | 12 months later | p value |
| BUN (mg/dL) | 23.6±8.4 | 23.8±8.5 | 0.7871 | 43.3±15.4 | 56.6±18.2 | 0.0069 |
| Scr (mg/dL) | 1.2±0.4 | 1.3±0.4 | 0.1318 | 3.0±1.2 | 4.4±2.3 | 0.0006 |
| CCr (mL/min) | 52.5±13.9 | 50.8±15.7 | 0.3226 | 21.0±10.0 | 14.1±6.3 | 0.0011 |
| eGFR (mL/min/1.73m2) | 43.9±9.9 | 41.9±11.5 | 0.2987 | 18.6±9.0 | 12.3±5.5 | 0.0004 |